These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 19859715

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effect of infliximab on sight-threatening panuveitis in Behçet's disease.
    Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN.
    Lancet; 2001 Jul 28; 358(9278):295-6. PubMed ID: 11498218
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.
    Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Hanami K, Tanaka Y.
    Mod Rheumatol; 2011 Apr 28; 21(2):184-91. PubMed ID: 21052764
    [Abstract] [Full Text] [Related]

  • 26. Long-term efficacy and safety of infliximab in the treatment of Behçet's disease.
    Capella MJ, Foster CS.
    Ocul Immunol Inflamm; 2012 Jun 28; 20(3):198-202. PubMed ID: 22486265
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.
    Takeuchi M, Kezuka T, Sugita S, Keino H, Namba K, Kaburaki T, Maruyama K, Nakai K, Hijioka K, Shibuya E, Komae K, Hori J, Ohguro N, Sonoda KH, Mizuki N, Okada AA, Ishibashi T, Goto H, Mochizuki M.
    Ophthalmology; 2014 Oct 28; 121(10):1877-84. PubMed ID: 24950593
    [Abstract] [Full Text] [Related]

  • 28. Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis.
    Takase K, Ohno S, Ideguchi H, Uchio E, Takeno M, Ishigatsubo Y.
    Rheumatol Int; 2011 Feb 28; 31(2):243-5. PubMed ID: 19816689
    [Abstract] [Full Text] [Related]

  • 29. 74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis.
    Delabaye I, De Keyser F, REMITRACT study group.
    Arthritis Res Ther; 2010 Feb 28; 12(3):R121. PubMed ID: 20569501
    [Abstract] [Full Text] [Related]

  • 30. Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.
    Fujikawa K, Aratake K, Kawakami A, Aramaki T, Iwanaga N, Izumi Y, Arima K, Kamachi M, Tamai M, Huang M, Nakamura H, Nishiura Y, Origuchi T, Ida H, Eguchi K.
    Ann Rheum Dis; 2007 Jan 28; 66(1):136-7. PubMed ID: 17178762
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS, Kay J, Doyle MK, Landewé R, Matteson EL, Wollenhaupt J, Gaylis N, Murphy FT, Neal JS, Zhou Y, Visvanathan S, Hsia EC, Rahman MU, GO-AFTER study investigators.
    Lancet; 2009 Jul 18; 374(9685):210-21. PubMed ID: 19560810
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Refractory pseudoseptic arthritis in Behçet's disease successfully treated with infliximab: a case report and literature review.
    Sifuentes Giraldo WA, Guillén Astete CA, Murillo Romero C, Amil Casas I, Rodríguez García AM, Bachiller Corral FJ.
    Mod Rheumatol; 2014 Jan 18; 24(1):199-205. PubMed ID: 24261779
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
    Lopez-Gonzalez R, Loza E, Jover JA, Benitez Del Castillo JM, Mendez R, Hernandez-Garcia C, Pato E.
    Scand J Rheumatol; 2009 Jan 18; 38(1):58-62. PubMed ID: 18991187
    [Abstract] [Full Text] [Related]

  • 39. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.
    Suhler EB, Smith JR, Wertheim MS, Lauer AK, Kurz DE, Pickard TD, Rosenbaum JT.
    Arch Ophthalmol; 2005 Jul 18; 123(7):903-12. PubMed ID: 16009830
    [Abstract] [Full Text] [Related]

  • 40. Good response to infliximab in a patient with deep vein thrombosis associated with Behçet disease.
    Yoshida S, Takeuchi T, Yoshikawa A, Ozaki T, Fujiki Y, Hata K, Makino S, Hanafusa T.
    Mod Rheumatol; 2012 Sep 18; 22(5):791-5. PubMed ID: 22245952
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.